Avsar.
3B

Healthcare · Healthcare Service Provider

3B Blackbio DX Ltd (3BBLACKBIO)

₹1,624.70

Mkt cap
₹1,132 Cr
P/E ratio
20.40
P/B
4.30
Div yield
0.38%
ROE
19.80%
ROCE
25.50%
EPS (TTM)
₹79.64
Book value
₹378
52W range
1,085–1,740
Sector
Healthcare

Price history

Previous close

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products [1]

NSE 3BBLACKBIOBSE 532067
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−6.63% from high
₹1,625
₹1,085+49.74% from low₹1,740
Current
₹1,624.70
Prev close
₹1,646.80
Day
−1.34%
Price performance
1D
−2.26%
1W
+10.53%
1M
+8.86%
3M
+33.30%
6M
—
1Y
—
YTD
+24.79%

Financials

Revenue, profit & margin
P/E ratio
20.4×
3BBLACKBIO is 44% below the sector median of 36.5×
3BBLACKBIO20.4×
Sector median36.5×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales14.2819.1817.6723.0019.4329.1525.3922.5022.2333.9050.3535.4333.49
Expenses7.8411.398.8013.128.4812.9810.3214.5810.4019.1728.6326.9424.97
Operating Profit6.447.798.879.8810.9516.1715.077.9211.8314.7321.728.498.52
OPM %45.10%40.62%50.20%42.96%56.36%55.47%59.35%35.20%53.22%43.45%43.14%23.96%25.44%
Other Income2.962.752.634.193.693.443.014.944.325.515.5910.156.14
Interest0.020.040.030.040.010.030.020.040.010.040.090.100.10
Depreciation0.190.240.320.300.270.270.270.280.280.580.383.891.34
Profit before tax9.1910.2611.1513.7314.3619.3117.7912.5415.8619.6226.8414.6513.22
Tax %21.55%26.02%23.68%35.98%21.31%22.99%24.17%35.89%20.30%23.34%16.39%33.11%32.07%
Net Profit7.217.588.518.7911.3014.8713.498.0412.6515.0422.449.818.98
EPS in Rs9.7110.4610.1610.3312.9717.0715.619.7914.6717.1425.3211.1411.10
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
40.95%Promoter
Promoters40.95%0.01
FIIs2.50%0.07
DIIs2.15%0.17
Public54.40%0.10
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹1,896.9056.6331,8390.74%171+28.02%798+19.10%28.00%
Vijaya Diagnost.₹1,558.9085.6416,0560.13%53+37.60%231+22.83%20.53%
Metropolis Healt₹597.4559.5512,3940.33%57+25.77%450+16.62%17.81%
Thyrocare Tech.₹555.8048.958,8461.68%51+34.06%240+24.34%35.38%
Nephrocare Health Services₹743.3587.837,4750.00%32+34.89%282+23.69%15.34%
Krsnaa Diagnost.₹541.1517.741,7550.37%16−19.12%211+19.95%12.70%
Suraksha Diagno.₹335.1048.751,7450.15%13+38.40%88+20.75%17.29%
3B Blackbio₹1,319.3020.391,1320.38%9−24.31%33+50.65%25.48%
Median: 17 Co.₹335.1036.541,0530.00%11+28.02%95+19.10%20.53%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Concall transcripts49
PPTAug 2026TranscriptJun 2026RECJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026PPTNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025PPTMay 2025PPTFeb 2025PPTNov 2024PPTAug 2024PPTMay 2024PPTFeb 2024PPTNov 2023PPTAug 2023PPTMay 2023PPTFeb 2023PPTNov 2022PPTSep 2022
Credit ratings4
Rating update 11 Mar 2019careRating update 2 Feb 2018careRating update 10 Jan 2017careRating update 21 Apr 2015crisil
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 18 Sep - Special Window for Re-lodgement of Transfer Requests of Physical sharesAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Sep - 3B BlackBio Dx met Marcellus Investment Managers on 16 Sep 2026; no UPSI shared.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 SepAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 11 Sep - 3B BlackBio Dx held one-to-one investor meeting with Capri Global Holdings on 11 September 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Sep